Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).
from News Medical Medical Research News Feed https://ift.tt/3nTzPtJ
0 Comments